Literature DB >> 19305750

Pharmaceutical use and outcomes: always a need for a sober second look.

Steve Morgan1, Brenda Macgibbon.   

Abstract

Year:  2007        PMID: 19305750      PMCID: PMC2645128     

Source DB:  PubMed          Journal:  Healthc Policy        ISSN: 1715-6572


× No keyword cloud information.
  9 in total

1.  Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach.

Authors:  Andreas Laupacis; J Michael Paterson; Muhammad Mamdani; Alaa Rostom; Geoffrey M Anderson
Journal:  CMAJ       Date:  2003-11-25       Impact factor: 8.262

2.  Emergent patterns in the regulation of pharmaceuticals: institutions and interests in the United States, Canada, Britain, and France.

Authors:  Mary E Wiktorowicz
Journal:  J Health Polit Policy Law       Date:  2003-08       Impact factor: 2.265

3.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

Authors:  Sean R Tunis; Daniel B Stryer; Carolyn M Clancy
Journal:  JAMA       Date:  2003-09-24       Impact factor: 56.272

4.  Gaps, tensions, and conflicts in the FDA approval process: implications for clinical practice.

Authors:  Richard A Deyo
Journal:  J Am Board Fam Pract       Date:  2004 Mar-Apr

Review 5.  Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization.

Authors:  Patricia A Caetano; Jonathan M C Lam; Steven G Morgan
Journal:  Clin Ther       Date:  2006-09       Impact factor: 3.393

6.  Costs of new atypical antipsychotic agents for schizophrenia: does unrestricted access reduce hospital utilization?

Authors:  Daria O'Reilly; David Craig; Leslie Phillips; Ron Goeree; Jean-Eric Tarride; Patrick Parfrey
Journal:  Healthc Policy       Date:  2007-08

Review 7.  Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens.

Authors:  J Urquhart
Journal:  Pharmacoeconomics       Date:  1999-03       Impact factor: 4.981

8.  Patients' consent preferences for research uses of information in electronic medical records: interview and survey data.

Authors:  Donald J Willison; Karim Keshavjee; Kalpana Nair; Charlie Goldsmith; Anne M Holbrook
Journal:  BMJ       Date:  2003-02-15

9.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.